AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 35 filers reported holding AURA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189,123 | -81.0% | 21,084 | -73.9% | 0.00% | – |
Q2 2023 | $996,212 | +47.9% | 80,665 | +11.1% | 0.00% | – |
Q1 2023 | $673,664 | -0.7% | 72,593 | +12.4% | 0.00% | – |
Q4 2022 | $678,333 | -32.2% | 64,603 | +17.1% | 0.00% | – |
Q3 2022 | $1,000,000 | +29.5% | 55,152 | +1.1% | 0.00% | – |
Q2 2022 | $772,000 | +3116.7% | 54,539 | +4817.9% | 0.00% | – |
Q1 2022 | $24,000 | +166.7% | 1,109 | +107.7% | 0.00% | – |
Q4 2021 | $9,000 | – | 534 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $66,878,000 | 18.12% |
Decheng Capital Management III (Cayman), LLC | 210,000 | $4,620,000 | 1.42% |
Matrix Capital Management Company, LP | 4,112,870 | $90,483,000 | 1.09% |
Rock Springs Capital Management LP | 1,008,114 | $22,179,000 | 0.56% |
Nantahala Capital Management | 301,990 | $6,644,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,297,019 | $28,534,000 | 0.05% |
Citadel Advisors | 2,316,653 | $48,263,000 | 0.01% |
Allianz Asset Management GmbH | 55,145 | $1,213,000 | 0.00% |
BARCLAYS PLC | 59,697 | $1,314,000 | 0.00% |
FMR LLC | 494,109 | $10,870,000 | 0.00% |